SKY-0515

Name: SKY-0515 in Huntington's disease: Model outcomes
Published: 2026-09-16T18:00:43-04:00

Huntington's disease

Manufacturer: Skyhawk Therapeutics
Regulatory submission: TGA provisional approval application submitted March 2026
Launch: Anticipated as early as 2027, market not specified
Last updated: October 1, 2026

Section

Economic information and modeling report Budget impact model

Model outcomes

1 evidence topic · 1 source

Budget impact model: reporting of results (AMCP Format, version 5.0)

“When reporting the economic impact of the intervention, it is recommended to present the findings as both the” (opens the source at this quote in a new tab)
“PMPM cost difference and the overall budget impact on the health system. Results may also include cost per-treated member per-month (PTMPM).” (opens the source at this quote in a new tab)